Amudha Deivasigamani

1.2k total citations
24 papers, 912 citations indexed

About

Amudha Deivasigamani is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Amudha Deivasigamani has authored 24 papers receiving a total of 912 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Molecular Biology, 8 papers in Cancer Research and 7 papers in Oncology. Recurrent topics in Amudha Deivasigamani's work include Cancer Mechanisms and Therapy (6 papers), Cytokine Signaling Pathways and Interactions (5 papers) and PI3K/AKT/mTOR signaling in cancer (4 papers). Amudha Deivasigamani is often cited by papers focused on Cancer Mechanisms and Therapy (6 papers), Cytokine Signaling Pathways and Interactions (5 papers) and PI3K/AKT/mTOR signaling in cancer (4 papers). Amudha Deivasigamani collaborates with scholars based in Singapore, China and India. Amudha Deivasigamani's co-authors include Kam M. Hui, Hongping Xia, Shik Nie Kong, Gautam Sethi, London Lucien Ooi, Chakrabhavi Dhananjaya Mohan, Kanchugarakoppal S. Rangappa, Jianxiang Chen, Karthik Sekar and Brian K. P. Goh and has published in prestigious journals such as Journal of Biological Chemistry, The EMBO Journal and Gut.

In The Last Decade

Amudha Deivasigamani

24 papers receiving 911 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Amudha Deivasigamani Singapore 14 561 311 203 151 108 24 912
Shokooh Salimimoghadam Iran 22 863 1.5× 545 1.8× 258 1.3× 193 1.3× 108 1.0× 49 1.4k
Sundaramoorthy Revathidevi India 10 603 1.1× 298 1.0× 146 0.7× 110 0.7× 97 0.9× 16 1.0k
Peng Zou China 13 644 1.1× 256 0.8× 208 1.0× 194 1.3× 53 0.5× 25 1.1k
Haolong Li China 15 689 1.2× 322 1.0× 184 0.9× 367 2.4× 44 0.4× 35 1.2k
Liyan Chen China 18 581 1.0× 164 0.5× 160 0.8× 113 0.7× 66 0.6× 33 851
Fanni Li China 17 448 0.8× 157 0.5× 196 1.0× 75 0.5× 50 0.5× 39 871
Sung Hee Hong South Korea 17 466 0.8× 180 0.6× 109 0.5× 50 0.3× 51 0.5× 57 849
Hongzhuan Yin China 19 539 1.0× 253 0.8× 115 0.6× 164 1.1× 67 0.6× 35 915
Xuejiao Song China 19 508 0.9× 122 0.4× 219 1.1× 67 0.4× 84 0.8× 37 943
Anuradha Kirtonia India 10 563 1.0× 284 0.9× 173 0.9× 106 0.7× 47 0.4× 12 904

Countries citing papers authored by Amudha Deivasigamani

Since Specialization
Citations

This map shows the geographic impact of Amudha Deivasigamani's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Amudha Deivasigamani with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Amudha Deivasigamani more than expected).

Fields of papers citing papers by Amudha Deivasigamani

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Amudha Deivasigamani. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Amudha Deivasigamani. The network helps show where Amudha Deivasigamani may publish in the future.

Co-authorship network of co-authors of Amudha Deivasigamani

This figure shows the co-authorship network connecting the top 25 collaborators of Amudha Deivasigamani. A scholar is included among the top collaborators of Amudha Deivasigamani based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Amudha Deivasigamani. Amudha Deivasigamani is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Harsha, Kachigere B., Amudha Deivasigamani, Chakrabhavi Dhananjaya Mohan, et al.. (2024). A new 1,2,3-triazole-indirubin hybrid suppresses tumor growth and pulmonary metastasis by mitigating the HGF/c-MET axis in hepatocellular carcinoma. Journal of Advanced Research. 73. 341–356. 12 indexed citations
2.
Basappa, Basappa, M. Mahendra, Kanchugarakoppal S. Rangappa, et al.. (2024). A novel drug prejudice scaffold-imidazopyridine-conjugate can promote cell death in a colorectal cancer model by binding to β-catenin and suppressing the Wnt signaling pathway. Journal of Advanced Research. 72. 615–632. 7 indexed citations
3.
Jung, Young Yun, Dongwoo Nam, Amudha Deivasigamani, et al.. (2024). TMP: A dual modulator of apoptosis and autophagy via SHP-1 regulation in hepatocellular carcinoma. Life Sciences. 361. 123316–123316. 1 indexed citations
4.
Lee, Mina, Amudha Deivasigamani, Duc Dat Le, et al.. (2023). Decanoic Acid Exerts Its Anti-Tumor Effects via Targeting c-Met Signaling Cascades in Hepatocellular Carcinoma Model. Cancers. 15(19). 4681–4681. 9 indexed citations
5.
Jung, Young Yun, Chulwon Kim, Muthu K. Shanmugam, et al.. (2023). Leonurine ameliorates the STAT3 pathway through the upregulation of SHP-1 to retard the growth of hepatocellular carcinoma cells. Cellular Signalling. 114. 111003–111003. 7 indexed citations
6.
Zhang, Jingwen, Young Yun Jung, Chakrabhavi Dhananjaya Mohan, et al.. (2022). Nimbolide enhances the antitumor effect of docetaxel via abrogation of the NF-κB signaling pathway in prostate cancer preclinical models. Biochimica et Biophysica Acta (BBA) - Molecular Cell Research. 1869(12). 119344–119344. 12 indexed citations
7.
Loo, Ser Yue, Nicholas Syn, Amudha Deivasigamani, et al.. (2021). Epigenetic derepression converts PPARγ into a druggable target in triple-negative and endocrine-resistant breast cancers. Cell Death Discovery. 7(1). 265–265. 12 indexed citations
8.
Mohan, Chakrabhavi Dhananjaya, Min Yang, Shobith Rangappa, et al.. (2021). 3-Formylchromone Counteracts STAT3 Signaling Pathway by Elevating SHP-2 Expression in Hepatocellular Carcinoma. Biology. 11(1). 29–29. 23 indexed citations
9.
Jiang, Xiaodan, Yan Jiang, Karthik Sekar, et al.. (2021). Correlation of NUF2 Overexpression with Poorer Patient Survival in Multiple Cancers. Cancer Research and Treatment. 53(4). 944–961. 18 indexed citations
10.
Chen, Hongjin, Haojun Xu, Min Ding, et al.. (2021). Centromere protein F promotes progression of hepatocellular carcinoma through ERK and cell cycle-associated pathways. Cancer Gene Therapy. 29(7). 1033–1042. 15 indexed citations
11.
Lee, Jong Hyun, Chakrabhavi Dhananjaya Mohan, Amudha Deivasigamani, et al.. (2020). Brusatol suppresses STAT3-driven metastasis by downregulating epithelial-mesenchymal transition in hepatocellular carcinoma. Journal of Advanced Research. 26. 83–94. 120 indexed citations
12.
Xia, Hongping, Jianxiang Chen, Hengjun Gao, et al.. (2019). Hypoxia-induced modulation of glucose transporter expression impacts 18F-fluorodeoxyglucose PET-CT imaging in hepatocellular carcinoma. European Journal of Nuclear Medicine and Molecular Imaging. 47(4). 787–797. 33 indexed citations
13.
Chen, Jianxiang, Hongping Xia, Shik Nie Kong, et al.. (2018). CDK 1‐mediated BCL 9 phosphorylation inhibits clathrin to promote mitotic Wnt signalling. The EMBO Journal. 37(20). 22 indexed citations
14.
Mohan, Chakrabhavi Dhananjaya, Hanumantharayappa Bharathkumar, Shobith Rangappa, et al.. (2018). N-Substituted Pyrido-1,4-Oxazin-3-Ones Induce Apoptosis of Hepatocellular Carcinoma Cells by Targeting NF-κB Signaling Pathway. Frontiers in Pharmacology. 9. 1125–1125. 38 indexed citations
15.
Gao, Bo, Karthik Sekar, Amudha Deivasigamani, et al.. (2017). A genome-wide CRISPR cell growth screen identifies NCAPG as a new therapeutic target for hepatocellular carcinoma. Annals of Oncology. 28. vii14–vii14. 2 indexed citations
16.
Xia, Hongping, Jianxiang Chen, Shik Nie Kong, et al.. (2017). Simultaneous silencing of ACSL4 and induction of GADD45B in hepatocellular carcinoma cells amplifies the synergistic therapeutic effect of aspirin and sorafenib. Cell Death Discovery. 3(1). 17058–17058. 43 indexed citations
17.
Han, Jianyu, Hongping Xia, Yafeng Wu, et al.. (2016). Single-layer MoS2nanosheet grafted upconversion nanoparticles for near-infrared fluorescence imaging-guided deep tissue cancer phototherapy. Nanoscale. 8(15). 7861–7865. 87 indexed citations
18.
Chen, Jianxiang, Hongping Xia, Xiaoqian Zhang, et al.. (2016). The microtubule-associated protein PRC1 promotes early recurrence of hepatocellular carcinoma in association with the Wnt/β-catenin signalling pathway. Gut. 65(9). 1522–1534. 174 indexed citations
19.
Chen, Xiao, Tianming Yang, Amudha Deivasigamani, et al.. (2015). N′‐Alkylaminosulfonyl Analogues of 6‐Fluorobenzylideneindolinones with Desirable Physicochemical Profiles and Potent Growth Inhibitory Activities on Hepatocellular Carcinoma. ChemMedChem. 10(9). 1548–1558. 12 indexed citations
20.
Mohan, Chakrabhavi Dhananjaya, Hanumantharayappa Bharathkumar, Krishna C. Bulusu, et al.. (2014). Development of a Novel Azaspirane That Targets the Janus Kinase-Signal Transducer and Activator of Transcription (STAT) Pathway in Hepatocellular Carcinoma in Vitro and in Vivo. Journal of Biological Chemistry. 289(49). 34296–34307. 149 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026